Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription Articles published in BMJ Retrieve available abstracts of 129 articles: HTML format

Single Articles

December 2024
1. MOTTELSON M, Helby J, Nordestgaard BG, Ellervik C, et al
   Mortality and risk of diabetes, liver disease, and heart disease in individuals with haemochromatosis HFE C282Y homozygosity and normal concentrations of iron, transferrin saturation, or ferritin: prospective cohort study.
   BMJ. 2024;387:e079147.
   PubMed     Abstract available
   
   
   
2. LIU B, Zong G, Zhu L, Hu Y, et al
   Chocolate intake and risk of type 2 diabetes: prospective cohort studies.
   BMJ. 2024;387:e078386.
   PubMed     Abstract available
   
   
   November 2024
3. IACOBUCCI G
   Diabetes: Global treatment gap is widening, study finds.
   BMJ. 2024;387:q2515.
   PubMed    
   
   
   
4. SCIVIER M
   Quality care is needed for older people with diabetes in care homes-now and for the future.
   BMJ. 2024;387:q2471.
   PubMed    
   
   
   
5. SVANSTROM H, Mkoma GF, Hviid A, Pasternak B, et al
   SGLT-2 inhibitors and mortality among patients with heart failure with reduced ejection fraction: linked database study.
   BMJ. 2024;387:e080925.
   PubMed     Abstract available
   
   
   October 2024
6. MCCORMICK N, Yokose C, Lu N, Wexler DJ, et al
   Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for recurrent nephrolithiasis among patients with pre-existing nephrolithiasis or gout: target trial emulation studies.
   BMJ. 2024;387:e080035.
   PubMed     Abstract available
   
   
   
7. ALKABBANI W, Suissa K, Gu KD, Cromer SJ, et al
   Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study.
   BMJ. 2024;387:e080340.
   PubMed     Abstract available
   
   
   
8. MENG LC, van Gelder MMHJ, Chuang HM, Chen LK, et al
   Paternal metformin use and risk of congenital malformations in offspring in Norway and Taiwan: population based, cross national cohort study.
   BMJ. 2024;387:e080127.
   PubMed     Abstract available
   
   
   
9. LIU L, Ke W, Li H, Li F, et al
   Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia: multicentre, open label, randomised trial.
   BMJ. 2024;387:e080122.
   PubMed     Abstract available
   
   
   
10. AGARWAL A, Zeng X, Li S, Rayner D, et al
    Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline.
    BMJ. 2024;387:e080257.
    PubMed     Abstract available
    
    
    September 2024
11. WISE J
    Diabetes: Once weekly insulin could be as effective as daily injections, studies indicate.
    BMJ. 2024;386:q2005.
    PubMed    
    
    
    
12. 
    Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study.
    BMJ. 2024;386:q1911.
    PubMed    
    
    
    August 2024
13. TU SY, Shao SC, Loh CH, Huang HK, et al
    SGLT-2 inhibitors and dementia.
    BMJ. 2024;386:q1841.
    PubMed    
    
    
    
14. MAHASE E
    Semaglutide's CVD indication could cost US Medicare $145bn extra a year.
    BMJ. 2024;386:q1878.
    PubMed    
    
    
    
15. SHIN A, Koo BK, Lee JY, Kang EH, et al
    Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study.
    BMJ. 2024;386:e079475.
    PubMed     Abstract available
    
    
    
16. KMIETOWICZ Z
    SGLT-2 inhibitors for diabetes may help prevent dementia, study finds.
    BMJ. 2024;386:q1875.
    PubMed    
    
    
    
17. MAHASE E
    Diabetes: One in 10 patients on NHS's "soups and shakes" diet plan went into remission.
    BMJ. 2024;386:q1733.
    PubMed    
    
    
    July 2024
18. MAHASE E
    Semaglutide: FDA publishes warning amid reports of patients overdosing.
    BMJ. 2024;386:q1696.
    PubMed    
    
    
    
19. IACOBUCCI G
    Semaglutide: UK regulator approves drug for prevention of cardiovascular events.
    BMJ. 2024;386:q1660.
    PubMed    
    
    
    
20. MAHASE E
    GLP-1 agonists: US sees 700% increase over four years in number of patients without diabetes starting treatment.
    BMJ. 2024;386:q1645.
    PubMed    
    
    
    
21. LAL N
    India: Doctors report surge in use of off label GLP-1 agonists among rich.
    BMJ. 2024;386:q1605.
    PubMed    
    
    
    
22. DYER C
    People with type 1 diabetes and disordered eating need joined-up care, says coroner after woman's death.
    BMJ. 2024;386:q1597.
    PubMed    
    
    
    
23. VANDERPANT N, Ward E, Farrell E, Theodoraki A, et al
    Insulin for people with type 2 diabetes mellitus.
    BMJ. 2024;386:e078015.
    PubMed    
    
    
    
24. WISE J
    Covid-19: Progression to clinical type 1 diabetes accelerated after infection, study suggests.
    BMJ. 2024;386:q1557.
    PubMed    
    
    
    
25. SETHI J
    Use of language in diabetes: what's in a name?
    BMJ. 2024;386:q1446.
    PubMed    
    
    
    June 2024
26. MAHASE E
    GLP-1 shortages will not resolve this year, EMA warns, amid concern over off-label use.
    BMJ. 2024;385:q1448.
    PubMed    
    
    
    
27. FU EL, Wexler DJ, Cromer SJ, Bykov K, et al
    SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study.
    BMJ. 2024;385:e078483.
    PubMed     Abstract available
    
    
    
28. DOBLE E, Farrow D
    We need to tackle the increasing mountain of wasted plastic and cardboard from diabetes technologies.
    BMJ. 2024;385:q1337.
    PubMed    
    
    
    
29. ZHANG J, Li Y
    Increasing prevalence of type 1 diabetes in older age may be a good sign.
    BMJ. 2024;385:q1322.
    PubMed    
    
    
    
30. YANG K, Yang X, Jin C, Ding S, et al
    Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019: population based study.
    BMJ. 2024;385:e078432.
    PubMed     Abstract available
    
    
    
31. 
    New advances in type 1 diabetes.
    BMJ. 2024;385:q1224.
    PubMed    
    
    
    May 2024
32. JENKINS AJ, Ogle GD, Scibilia R, Schwarz P, et al
    People who need insulin are particularly vulnerable in disasters and conflicts.
    BMJ. 2024;385:q1109.
    PubMed    
    
    
    
33. BIDULKA P, Lugo-Palacios DG, Carroll O, O'Neill S, et al
    Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
    BMJ. 2024;385:e077097.
    PubMed     Abstract available
    
    
    April 2024
34. MAHASE E
    Diabetes UK defends partnership with Slimming World in face of criticism.
    BMJ. 2024;385:q962.
    PubMed    
    
    
    
35. SIMMS-WILLIAMS N, Treves N, Yin H, Lu S, et al
    Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:e078242.
    PubMed     Abstract available
    
    
    
36. NOLAN T
    The use of continuous glucose monitoring devices in non-diabetic adults ... and other research.
    BMJ. 2024;385:q859.
    PubMed    
    
    
    
37. SETHI J
    Breaking free from the stigma of diabetes.
    BMJ. 2024;385:q890.
    PubMed    
    
    
    
38. BOKINNI Y
    Barbados is in the grip of a diabetic foot amputation crisis.
    BMJ. 2024;385:q350.
    PubMed    
    
    
    
39. PASTERNAK B, Wintzell V, Hviid A, Eliasson B, et al
    Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
    BMJ. 2024;385:e078225.
    PubMed     Abstract available
    
    
    March 2024
40. CHRISTIE B
    Charity calls for Scottish government to increase access to diabetes technology.
    BMJ. 2024;384:q755.
    PubMed    
    
    
    
41. MAHASE E
    Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test.
    BMJ. 2024;384:q744.
    PubMed    
    
    
    
42. SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al
    Even short periods of diabetes remission are linked to lower risk of heart attack and stroke.
    BMJ. 2024;384:q516.
    PubMed     Abstract available
    
    
    
43. TANNE JH
    FDA approves first over-the-counter blood glucose monitor for diabetes.
    BMJ. 2024;384:q611.
    PubMed    
    
    
    
44. TANNE JH
    US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDA.
    BMJ. 2024;384:q569.
    PubMed    
    
    
    February 2024
45. LANE MM, Gamage E, Du S, Ashtree DN, et al
    Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses.
    BMJ. 2024;384:e077310.
    PubMed     Abstract available
    
    
    
46. KIM KS, Hong S, Han K, Park CY, et al
    Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study.
    BMJ. 2024;384:e076388.
    PubMed     Abstract available
    
    
    
47. BHALA N
    Liver steatosis linked to type 2 diabetes outcomes.
    BMJ. 2024;384:q309.
    PubMed    
    
    
    January 2024
48. YAO H, Zhang A, Li D, Wu Y, et al
    Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis.
    BMJ. 2024;384:e076410.
    PubMed     Abstract available
    
    
    
49. SUBRAMANIAN S, Khan F, Hirsch IB
    New advances in type 1 diabetes.
    BMJ. 2024;384:e075681.
    PubMed     Abstract available
    
    
    
50. IACOBUCCI G
    Artificial pancreases for type 1 diabetes: Better access is "watershed moment"-but delivery is key.
    BMJ. 2024;384:q102.
    PubMed    
    
    
    
51. IACOBUCCI G
    Fragmented care is failing people with type 1 diabetes related eating disorders, inquiry finds.
    BMJ. 2024;384:q178.
    PubMed    
    
    
    
52. PHIZACKERLEY D
    Semaglutide reduces the absolute risk of major cardiovascular events by 1.5.
    BMJ. 2024;384:q53.
    PubMed    
    
    
    December 2023
53. COURCOULAS AP, Daigle CR, Arterburn DE
    Long term outcomes of metabolic/bariatric surgery in adults.
    BMJ. 2023;383:e071027.
    PubMed     Abstract available
    
    
    
54. COHEN D
    GLP-1 receptor agonists: European drug regulator asks makers for evidence of self-harm.
    BMJ. 2023;383:2906.
    PubMed    
    
    
    
55. CHEN TK, Hoenig MP, Nitsch D, Grams ME, et al
    Advances in the management of chronic kidney disease.
    BMJ. 2023;383:e074216.
    PubMed     Abstract available
    
    
    November 2023
56. IACOBUCCI G
    Challenges in diabetes and obesity: five minutes with . . . Jonathan Valabhji.
    BMJ. 2023;383:p2831.
    PubMed    
    
    
    
57. IACOBUCCI G
    England's diabetes prevention programme has delivered causal benefits, study reports.
    BMJ. 2023;383:p2691.
    PubMed    
    
    
    
58. MAHASE E
    NICE recommends hybrid closed loop systems for poorly controlled type 1 diabetes.
    BMJ. 2023;383:p2619.
    PubMed    
    
    
    October 2023
59. KAR P
    Partha Kar: The time to tackle rising type 2 diabetes is T2DaY.
    BMJ. 2023;383:p2490.
    PubMed    
    
    
    
60. LEE YJ, Hong SJ, Kang WC, Hong BK, et al
    Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
    BMJ. 2023;383:e075837.
    PubMed     Abstract available
    
    
    
61. LADHER N, Hinton R, Veitch E
    Challenges of obesity and type 2 diabetes require more attention to food environment.
    BMJ. 2023;383:p2269.
    PubMed     Abstract available
    
    
    September 2023
62. WILL EJ
    SGLT2 inhibitors: here we go again?
    BMJ. 2023;382:2172.
    PubMed    
    
    
    
63. 
    Diagnosis and management of diabetes in children and young people: summary of updated NICE guidance.
    BMJ. 2023;382:p2072.
    PubMed    
    
    
    
64. FOU L, Agwu JC, Aswani N, Bakhai C, et al
    Glucose monitoring and glucose lowering agents for children and young people with type 2 diabetes: summary of updated NICE guidance.
    BMJ. 2023;382:p1686.
    PubMed    
    
    
    
65. MAHASE E
    Tirzepatide: NICE recommends another GLP-1 agonist for type 2 diabetes.
    BMJ. 2023;382:2074.
    PubMed    
    
    
    
66. IACOBUCCI G
    Diabetes: Doctors are told not to start new patients on GLP-1 agonists because of shortages.
    BMJ. 2023;382:2019.
    PubMed    
    
    
    July 2023
67. BRAITHWAITE B
    Risk of diabetes with statins: comparing apples with oranges.
    BMJ. 2023;382:p1720.
    PubMed    
    
    
    
68. IACOBUCCI G
    UK clinics told to stop prescribing antidiabetes drugs for weight loss, after shortages.
    BMJ. 2023;382:1693.
    PubMed    
    
    
    
69. HANNA F, Wu P, Heald A, Fryer A, et al
    Diabetes detection in women with gestational diabetes and polycystic ovarian syndrome.
    BMJ. 2023;382:e071675.
    PubMed     Abstract available
    
    
    June 2023
70. MAHASE E
    Tackling structural racism is crucial to ending global diabetes crisis, researchers say.
    BMJ. 2023;381:p1439.
    PubMed    
    
    
    
71. WISE J
    Covid-19: Metformin reduces the risk of developing long term symptoms by 40%, study finds.
    BMJ. 2023;381:p1306.
    PubMed    
    
    
    May 2023
72. GRAY M
    Preventing type 2 diabetes: public health campaigns should focus on living longer better.
    BMJ. 2023;381:p1139.
    PubMed    
    
    
    
73. MANSI IA, Sumithran P, Kinaan M
    Risk of diabetes with statins.
    BMJ. 2023;381:e071727.
    PubMed    
    
    
    
74. IACOBUCCI G
    Diabetes: Missed routine checks are causing premature deaths in England, charity warns.
    BMJ. 2023;381:1070.
    PubMed    
    
    
    
75. WHITE SL, Ayman G, Bakhai C, Hillier TA, et al
    Screening and diagnosis of gestational diabetes.
    BMJ. 2023;381:e071920.
    PubMed    
    
    
    April 2023
76. VALABHJI J, Kar P
    Rise in type 2 diabetes shows that prevention is more important than ever.
    BMJ. 2023;381:p910.
    PubMed    
    
    
    
77. 
    Rise in type 2 diabetes shows that prevention is more important than ever.
    BMJ. 2023;381:p941.
    PubMed    
    
    
    
78. SAUL H, Deeney B, Imison C, Tesfaye S, et al
    Combination therapy for painful diabetic neuropathy is safe and effective.
    BMJ. 2023;381:p866.
    PubMed     Abstract available
    
    
    
79. MA L, Hu Y, Alperet DJ, Liu G, et al
    Beverage consumption and mortality among adults with type 2 diabetes: prospective cohort study.
    BMJ. 2023;381:e073406.
    PubMed     Abstract available
    
    
    
80. FOROUHI NG
    Beverages and health outcomes in adults with type 2 diabetes.
    BMJ. 2023;381:p841.
    PubMed    
    
    
    
81. LYU H, Zhao SS, Zhang L, Wei J, et al
    Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study.
    BMJ. 2023;381:e073435.
    PubMed     Abstract available
    
    
    
82. WISE J
    Diabetes cases in UK reach all time high, charity warns.
    BMJ. 2023;381:p848.
    PubMed    
    
    
    
83. SHI Q, Nong K, Vandvik PO, Guyatt GH, et al
    Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2023;381:e074068.
    PubMed     Abstract available
    
    
    March 2023
84. MCCARTNEY M
    Semaglutide: should the media slim down its enthusiasm?
    BMJ. 2023;380:p624.
    PubMed    
    
    
    
85. WISE J
    Novo Nordisk suspended from industry body over serious breaches.
    BMJ. 2023;380:p634.
    PubMed    
    
    
    February 2023
86. CRUMP C, Sundquist J, McLaughlin MA, Dolan SM, et al
    Adverse pregnancy outcomes and long term risk of ischemic heart disease in mothers: national cohort and co-sibling study.
    BMJ. 2023;380:e072112.
    PubMed     Abstract available
    
    
    January 2023
87. IACOBUCCI G
    Type 1 diabetes: NICE recommends new "artificial pancreas" technology.
    BMJ. 2023;380:p55.
    PubMed    
    
    
    December 2022
88. XIE J, Wang M, Long Z, Ning H, et al
    Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019.
    BMJ. 2022;379:e072385.
    PubMed     Abstract available
    
    
    November 2022
89. TAYLOR L
    Diabetes prevalence in Americas tripled in 30 years.
    BMJ. 2022;379:o2868.
    PubMed    
    
    
    
90. IACOBUCCI G
    Type 1 diabetes: US approves drug that can delay onset.
    BMJ. 2022;379:o2798.
    PubMed    
    
    
    
91. PRADHAN R, Lu S, Yin H, Yu OHY, et al
    Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study.
    BMJ. 2022;379:e071380.
    PubMed     Abstract available
    
    
    October 2022
92. MULVIHILL C, Brooks A, Basudev N, Lincoln P, et al
    Continuous glucose monitoring for adults and children with diabetes: summary of updated NICE guidance.
    BMJ. 2022;379:o2418.
    PubMed    
    
    
    
93. HUANG C, Wei K, Lee PMY, Qin G, et al
    Maternal hypertensive disorder of pregnancy and mortality in offspring from birth to young adulthood: national population based cohort study.
    BMJ. 2022;379:e072157.
    PubMed     Abstract available
    
    
    
94. IKOMI AE
    It's time to widen the capture of gestational diabetes in the UK.
    BMJ. 2022;379:o2444.
    PubMed    
    
    
    
95. DENG Y, Polley EC, Wallach JD, Dhruva SS, et al
    Emulating the GRADE trial using real world data: retrospective comparative effectiveness study.
    BMJ. 2022;379:e070717.
    PubMed     Abstract available
    
    
    September 2022
96. MAHASE E
    Type 1 diabetes: Global prevalence is set to double by 2040, study estimates.
    BMJ. 2022;378:o2289.
    PubMed    
    
    
    
97. YANG J, Qian F, Chavarro JE, Ley SH, et al
    Modifiable risk factors and long term risk of type 2 diabetes among individuals with a history of gestational diabetes mellitus: prospective cohort study.
    BMJ. 2022;378:e070312.
    PubMed     Abstract available
    
    
    
98. XIE W, Wang Y, Xiao S, Qiu L, et al
    Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis.
    BMJ. 2022;378:e070244.
    PubMed     Abstract available
    
    
    August 2022
99. MARSTON L
    The failed promise of the US's Inflation Reduction Act for patients with diabetes.
    BMJ. 2022;378:o2086.
    PubMed    
    
    
    
100. HUSSAIN Z
     NHS to rollout continuous glucose monitors for all patients with type 1 diabetes.
     BMJ. 2022;378:o1935.
     PubMed    
     
     
     July 2022
101. WISE J
     Covid-19: Infection raises risk of diabetes and heart disease diagnoses in following weeks, study finds.
     BMJ. 2022;378:o1838.
     PubMed    
     
     
     June 2022
102. HE L, Wang J, Ping F, Yang N, et al
     Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials.
     BMJ. 2022;377:e068882.
     PubMed     Abstract available
     
     
     
103. WISE J
     Type 2 diabetes: Charity warns of "perfect storm" putting more children at risk.
     BMJ. 2022;377:o1451.
     PubMed    
     
     
     
104. WISE J
     Diabetes drug results in substantial weight loss in people with obesity, study finds.
     BMJ. 2022;377:o1406.
     PubMed    
     
     
     May 2022
105. 
     Vitamin D and risk of type 2 diabetes.
     BMJ. 2022;377:o1326.
     PubMed    
     
     
     
106. YE W, Luo C, Huang J, Li C, et al
     Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis.
     BMJ. 2022;377:e067946.
     PubMed     Abstract available
     
     
     
107. KAWAHARA T, Suzuki G, Mizuno S, Inazu T, et al
     Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population.
     BMJ. 2022;377:e066222.
     PubMed     Abstract available
     
     
     
108. CHRISTIDES T
     Vitamin D and risk of type 2 diabetes.
     BMJ. 2022;377:o1166.
     PubMed    
     
     
     
109. RUSSELL EL
     Managing type 1 diabetes: have faith in patients.
     BMJ. 2022;377:o1240.
     PubMed    
     
     
     
110. ARMSTRONG GRAY T, Hussain S, Gray M
     Empower young people with type 1 diabetes.
     BMJ. 2022;377:o1237.
     PubMed    
     
     
     
111. MORAN GM, Bakhai C, Song SH, Agwu JC, et al
     Type 2 diabetes: summary of updated NICE guidance.
     BMJ. 2022;377:o775.
     PubMed    
     
     
     April 2022
112. 
     SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline.
     BMJ. 2022;377:o1080.
     PubMed    
     
     
     
113. SAUL H, Gursul D, Cassidy S, Sharpe D, et al
     Why don't children and young people engage with diabetes services?
     BMJ. 2022;377:o750.
     PubMed     Abstract available
     
     
     
114. NG SM, Corbett T, Doble E, Brooks A, et al
     Managing the psychosocial impact of type 1 diabetes in young people.
     BMJ. 2022;377:e070530.
     PubMed    
     
     
     March 2022
115. IACOBUCCI G
     All patients with type 1 diabetes in England should be offered continuous glucose monitoring, says NICE.
     BMJ. 2022;376:o834.
     PubMed    
     
     
     
116. DYER C
     Young man who refused treatment for suspected type 1 diabetes died before palliative care plan was put in place.
     BMJ. 2022;376:o787.
     PubMed    
     
     
     
117. HODKINSON A, Tsimpida D, Kontopantelis E, Rutter MK, et al
     Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis.
     BMJ. 2022;376:e067731.
     PubMed     Abstract available
     
     
     February 2022
118. MAHASE E
     Type 1 diabetes drug was withdrawn because of a "commercial conflict of interest," charity argues.
     BMJ. 2022;376:o373.
     PubMed    
     
     
     
119. TANNE JH
     Diabetes kills 100 000 Americans for second year in a row.
     BMJ. 2022;376:o300.
     PubMed    
     
     
     January 2022
120. MAHMOOD A, Dar S, Dabhad A, Aksi B, et al
     Advising patients with existing conditions about fasting during Ramadan.
     BMJ. 2022;376:e063613.
     PubMed    
     
     
     
121. 
     Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
     BMJ. 2022;376:o109.
     PubMed    
     
     
     
122. JAYEDI A, Soltani S, Motlagh SZ, Emadi A, et al
     Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies.
     BMJ. 2022;376:e067516.
     PubMed     Abstract available
     
     
     
123. SLUGGETT JK, Rigby D
     Simplifying medications for people with type 2 diabetes.
     BMJ. 2022;376:n3158.
     PubMed    
     
     
     December 2021
124. GAHUNGU N, Trueick R, Coopes M, Gabbay E, et al
     Paroxysmal atrial fibrillation.
     BMJ. 2021;375:e058568.
     PubMed    
     
     
     
125. BESSER REJ, Ng SM, Robertson EJ
     Screening children for type 1 diabetes.
     BMJ. 2021;375:e067937.
     PubMed    
     
     
     November 2021
126. NOLAN T
     Tom Nolan's research reviews-26 November 2021.
     BMJ. 2021;375:n2938.
     PubMed    
     
     
     
127. AUBERT CE, Lega IC, Bourron O, Train AJ, et al
     When and how to deintensify type 2 diabetes care.
     BMJ. 2021;375:e066061.
     PubMed    
     
     
     October 2021
128. IACOBUCCI G
     One in 10 UK adults could have diabetes by 2030, warns charity.
     BMJ. 2021;375:n2453.
     PubMed    
     
     
     September 2021
129. SLIEKER RC, van der Heijden AAWA, Siddiqui MK, Langendoen-Gort M, et al
     Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
     BMJ. 2021;374:n2134.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.